These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27277334)

  • 1. Pharmacological interventions for clozapine-induced sinus tachycardia.
    Lally J; Docherty MJ; MacCabe JH
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011566. PubMed ID: 27277334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for antipsychotic-related constipation.
    Every-Palmer S; Newton-Howes G; Clarke MJ
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011128. PubMed ID: 28116777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic combinations for schizophrenia.
    Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano LE; Hu Y; Maayan N; Adams CE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009005. PubMed ID: 28658515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine dose for schizophrenia.
    Subramanian S; Völlm BA; Huband N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009555. PubMed ID: 28613395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for clozapine-induced hypersalivation.
    Syed R; Au K; Cahill C; Duggan L; He Y; Udu V; Xia J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD005579. PubMed ID: 18646130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpromazine versus penfluridol for schizophrenia.
    Nikvarz N; Vahedian M; Khalili N
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011831. PubMed ID: 28940256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson SJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006352. PubMed ID: 29893410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
    Deng H; Xu J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylsalicylic acid (aspirin) for schizophrenia.
    Schmidt L; Phelps E; Friedel J; Shokraneh F
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012116. PubMed ID: 31425623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zotepine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006628. PubMed ID: 20091601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorpromazine versus piperacetazine for schizophrenia.
    Eslami Shahrbabaki M; Dehnavieh R; Vali L; Sharafkhani R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011709. PubMed ID: 30378678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.